Related Experiment Video
Updated: May 23, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
Published on: November 11, 2020
Deposition of small particles in the developing lung
Israel Amirav1, Michael T Newhouse
1Pediatric Department, Ziv Medical Center, Safed, Faculty of Medicine, Technion, Haifa, Israel. amirav@012.net.il
Insights
Infants and young children require specialized aerosol delivery systems. Smaller particles and patient-friendly devices may improve inhaled corticosteroid (ICS) therapy effectiveness in this unique population.
Area of Science:
- Pediatric respiratory medicine
- Pharmacology
- Biomedical engineering
Background:
- Infants and young children (0-3 years) exhibit unique anatomical, physiological, and emotional characteristics impacting respiratory tract development and aerosol delivery.
- Current therapeutic aerosol studies, particularly for inhaled corticosteroids (ICS), often utilize large particles (>3 μm MMAD), designed for adults and older children.
- Mask-based delivery systems, common for ICS, are frequently rejected by children under 3-4 years of age.
Purpose of the Study:
- To review the challenges of aerosol delivery in infants and young children.
- To evaluate the efficacy of large-particle aerosols in this pediatric subpopulation.
- To propose the need for further research into smaller particle aerosols and improved delivery systems for pediatric patients.
Main Methods:
- Literature review focusing on aerosol particle size, delivery devices, and their impact on infants and young children.
- Analysis of anatomical, physiological, and emotional factors influencing aerosol deposition in the pediatric respiratory tract.
- Comparison of aerosol characteristics used in adult studies versus those potentially suitable for infants and young children.
Main Results:
- Large-particle aerosols (>3 μm MMAD) may be less effective for infants and young children due to their unique respiratory tract characteristics.
- Existing delivery systems, often mask-based, present challenges related to patient acceptance and adherence in very young children.
- The effectiveness of current inhaled medications in this age group warrants further investigation.
Conclusions:
- Optimizing aerosol therapy for infants and young children necessitates considering their specific developmental stage.
- Smaller particle aerosols and more patient-friendly delivery systems hold promise for improving therapeutic outcomes.
- Further research is crucial to determine the optimal aerosol characteristics and delivery methods for effective pediatric respiratory treatment.
Abstract:
Infancy is a time of marked and rapid changes in respiratory tract development. Infants (0-1 year of age) and young children (1- 3 years of age) are a unique subpopulation with regard to therapeutic aerosols. Anatomical, physiological and emotional factors, peculiar to these age groups, present significant challenges for aerosol delivery to the respiratory tract. Most studies with inhaled corticosteroids (ICS) have administered aerosols with relatively large particles, frequently > 3 μm in mass median aerodynamic diameter (MMAD). These drugs were designed for use in adults and older children and were administered with masks which were frequently rejected by children under age 3-4 years. We review the reasons that large-particle aerosols are likely to be less effective in infants and young children. We suggest that the benefit of inhaled medications in this age group requires further evaluation to determine if better therapeutic outcomes might be achieved using smaller particles and more patient-friendly delivery systems.
More Related Videos
09:45Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease
Published on: April 12, 2021
08:58Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Related Concept Videos
Breathing
Alveoli and Alveolar Ducts
Pulmonary Embolism I: Introduction
Pleura of the Lungs
Cleavage and Blastulation